BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12095557)

  • 1. Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia.
    Hurwitz MD; Kaplan ID; Hansen JL; Prokopios-Davos S; Topulos GP; Wishnow K; Manola J; Bornstein BA; Hynynen K
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):913-8. PubMed ID: 12095557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile.
    Hurwitz MD; Kaplan ID; Hansen JL; Prokopios-Davos S; Topulos GP; Wishnow K; Manola J; Bornstein BA; Hynynen K
    Int J Hyperthermia; 2005 Nov; 21(7):649-56. PubMed ID: 16278168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer.
    Hurwitz MD; Kaplan ID; Svensson GK; Hynynen K; Hansen MS
    Int J Hyperthermia; 2001; 17(1):31-7. PubMed ID: 11212878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and toxicity of transrectal ultrasound hyperthermia in the treatment of locally advanced adenocarcinoma of the prostate.
    Fosmire H; Hynynen K; Drach GW; Stea B; Swift P; Cassady JR
    Int J Radiat Oncol Biol Phys; 1993 May; 26(2):253-9. PubMed ID: 8491683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters.
    Rau B; Wust P; Tilly W; Gellermann J; Harder C; Riess H; Budach V; Felix R; Schlag PM
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):381-91. PubMed ID: 10974451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma--a feasibility study.
    van Vulpen M; Raaymakers BW; Lagendijk JJ; Crezee J; de Leeuw AA; van Moorselaar JR; Ligtvoet CM; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):116-26. PubMed ID: 12007949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153.
    Hurwitz MD; Hansen JL; Prokopios-Davos S; Manola J; Wang Q; Bornstein BA; Hynynen K; Kaplan ID
    Cancer; 2011 Feb; 117(3):510-6. PubMed ID: 20886629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.
    Skwarchuk MW; Jackson A; Zelefsky MJ; Venkatraman ES; Cowen DM; Levegrün S; Burman CM; Fuks Z; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):103-13. PubMed ID: 10758311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intra-luminal versus intra-tumoural temperature measurements in patients with locally advanced prostate cancer treated with the coaxial TEM system: report of a feasibility study.
    Van Vulpen M; De Leeuw AA; Van De Kamer JB; Kroeze H; Boon TA; Wárlám-Rodenhuis CC; Lagendijk JJ; Battermann JJ
    Int J Hyperthermia; 2003; 19(5):481-97. PubMed ID: 12944164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0.
    Tilly W; Gellermann J; Graf R; Hildebrandt B; Weissbach L; Budach V; Felix R; Wust P
    Strahlenther Onkol; 2005 Jan; 181(1):35-41. PubMed ID: 15660191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
    Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
    Aillères N; Azria D; Thézenas S; Barbier N; Fenoglietto P; Delard R; Hay MH; Dubois JB
    Cancer Radiother; 2004 Apr; 8(2):59-69. PubMed ID: 15063872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
    Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
    Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patients.
    Tanaka T; Yorozu A; Sutani S; Yagi Y; Nishiyama T; Shiraishi Y; Ohashi T; Hanada T; Saito S; Toya K; Shigematsu N
    Brachytherapy; 2018; 17(5):799-807. PubMed ID: 29936128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.